CRDF SG&A Expense Growth
Cardiff Oncology Inc · SG&A Expense Growth
CRDF SG&A Expense Growth
Latest reported13.96%period ending
CRDF FY SG&A Growth (YoY) (0.00% → 13.96%)
Latest values, visible window
High-resolution chart · PNG
CRDF sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 13.9561% | |
| -4.3012% | |
| -1.047% | |
| 11.3448% | |
| 44.0672% | |
| 42.6342% | |
| -28.0428% | |
| -43.7465% | |
| -38.119% | |
| 60.1156% | |
| 68.0983% | |
| 22.0331% | |
| 107.2109% | |
| 45.4188% | |
| 18.9306% | |
| -11.9854% | |
| 0% | |
| 288.4096% | |
| 0% |